Effects of inhaled aerosolized iloprost and inhaled NO on pulmonary circulation and edema formation in ovine lung injury.
Although inhaled NO (iNO) has been shown to lower pulmonary pressures and edema accumulation in experimental acute lung injury, its clinical use has been questioned because of a lack of improvement in outcome, rebound phenomena, and potential toxicity. We investigated the effects of aerosolized iloprost, a stable prostacyclin analogue, compared with iNO on pulmonary pressures and lung edema in 20 female sheep with oleic acid lung injury. The most effective dose of iloprost was determined in healthy animals before the experiment. Anesthetized and ventilated sheep received a central venous oleic acid infusion and were continuously infused with Ringer lactate to achieve a positive fluid balance (5 mL.kg(-1).h(-1)). In the iNO group (n = 6), iNO (20 ppm) was administered continuously for 8 h. Animals in the iloprost group (n = 6) received aerosolized iloprost (40 microg 2 h(-1)). Animals in the control group (n = 6) had no further intervention. Oleic acid infusion was associated with impaired oxygenation, pulmonary hypertension, and lung edema in all groups. Although iNO significantly decreased pulmonary vascular resistance index, effective pulmonary capillary pressure, and extravascular lung water index, these parameters were unaffected by iloprost. Oxygenation index (Pao2/Fio2) increased significantly both during NO and iloprost inhalation but also tended to improve in the control group over time. In contrast to iNO, the investigated dose of iloprost was ineffective to attenuate acute lung injury-induced changes in pulmonary hemodynamics and lung edema in this experimental model.
Hucklenbruch
Christoph
C
Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster, Münster, Germany. hucklenbruch@uni-muenster.de
Hinder
Frank
F
Berger
Christian
C
Ertmer
Christian
C
Lange
Matthias
M
Westphal
Martin
M
Van Aken
Hugo
H
Ellger
Björn
B
Dirk Stubbe
Henning
H
D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D005260:Female; D016285:Iloprost / Q000008:administration & dosage / Q000627:therapeutic use*; D055370:Lung Injury; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use*; D019301:Oleic Acid; D011652:Pulmonary Circulation / Q000187:drug effects*; D011654:Pulmonary Edema / Q000139:chemically induced / Q000209:etiology*; D012756:Sheep
D000336:Aerosols; D019301:Oleic Acid; D009569:Nitric Oxide; D016285:Iloprost